More about

Glucocorticoid

News
June 23, 2022
3 min read
Save

EULAR: Assess for PR3-MPO-ANCA as primary testing method for ANCA-associated vasculitis

EULAR: Assess for PR3-MPO-ANCA as primary testing method for ANCA-associated vasculitis

Rheumatologists should assess for PR3- and MPO-ANCA using a “high-quality antigen-specific assay” as the primary testing method for patients suspected of ANCA-associated vasculitis, according to updated EULAR recommendations.

News
June 21, 2022
3 min read
Save

Oral, inhaled corticosteroids associated with risk for adrenal insufficiency

Oral, inhaled corticosteroids associated with risk for adrenal insufficiency

Cumulative exposure to glucocorticoids appeared associated with risk for adrenal insufficiency among patients with severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

News
May 18, 2022
4 min read
Save

Though still used, glucocorticoid treatments ‘should be avoided’ in patients with RA

Though still used, glucocorticoid treatments ‘should be avoided’ in patients with RA

Glucocorticoids are still one of the most commonly used treatments for rheumatoid arthritis, with an estimated up to 50% of patients with RA in the United States using them long-term as of 2021.

News
March 16, 2022
36 min listen
Save

The Glucocorticoid Toxicity Index with John Stone, MD, MPH

The Glucocorticoid Toxicity Index with John Stone, MD, MPH

Glucocorticoids can do a lot of harm over time. In this episode, John Stone, MD, MPH, walks us through the Glucocorticoid Toxicity Index, a validated tool to measure steroid toxicity over time that we’ll be seeing more of in the future.

News
March 03, 2022
2 min read
Save

COVID-19 unlikely to ‘fade away’ for the immunocompromised: ‘It’s good to have options’

COVID-19 unlikely to ‘fade away’ for the immunocompromised: ‘It’s good to have options’

COVID-19 fears and complications are likely to persist far into the future for immunocompromised individuals, a speaker noted at the Basic and Clinical Immunology for the Busy Clinician symposium.

News
February 09, 2022
2 min read
Save

Physical therapy more cost-effective than glucocorticoids at 1 year in knee osteoarthritis

Physical therapy more cost-effective than glucocorticoids at 1 year in knee osteoarthritis

Although initially more expensive, a physical therapy course for knee osteoarthritis is more cost-effective after 1 year than a course of glucocorticoid injections, according to data published in JAMA Network Open.

News
December 11, 2021
2 min watch
Save

VIDEO: Expert discusses GLORIA trial results

VIDEO: Expert discusses GLORIA trial results

In this video from ACR Convergence 2021, Kathryn Dao, MD, provided insight on the data from the GLORIA trial, which found that steroids improved disease activity “but at a cost.”

News
December 07, 2021
2 min read
Save

Tocilizumab delays flare, reduces glucocorticoid dose in new-onset giant cell arteritis

Tocilizumab delays flare, reduces glucocorticoid dose in new-onset giant cell arteritis

Weekly tocilizumab delays initial flare and reduces glucocorticoid exposure in patients with relapsing and new-onset giant cell arteritis, according to data published in Rheumatology.

News
November 18, 2021
2 min read
Save

Early intervention 'cornerstone' to managing pediatric glucocorticoid-induced osteoporosis

Early intervention 'cornerstone' to managing pediatric glucocorticoid-induced osteoporosis

Early identification and timely intervention are key to treating children with glucocorticoid-induced osteoporosis, a preventive strategy outlined in five important principles by a speaker at ACR Convergence 2021.

News
November 17, 2021
3 min read
Save

'Just 30 days of glucocorticoid use' in RA spikes cardiovascular risk by 15% over 6 months

'Just 30 days of glucocorticoid use' in RA spikes cardiovascular risk by 15% over 6 months

Among patients with rheumatoid arthritis, 30 days of glucocorticoid use in 6 months is associated with 15% increased odds of major adverse cardiac events in the next 6 months, according to data presented at ACR Convergence 2021.

View more